NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 9, 2025 $30.00 +11.19% $25.27 X 81.28% 0
Sep 8, 2025 $27.87 +3.28% $25.48 X 90.64% 0
Sep 8, 2025 $27.53 +2.05% $25.48 X 91.94% 0
Sep 8, 2025 $29.00 +7.49% $25.48 X 86.19% 0
Sep 4, 2025 $27.77 +3.51% $26.53 X 95.32% 0
Sep 4, 2025 $26.24 -2.19% $26.53 V 98.91% 2
Sep 4, 2025 $32.00 +19.27% $26.53 X 79.38% 0
Sep 3, 2025 $26.53 -3.49% $26.83 V 98.88% 2
Sep 3, 2025 $26.89 -2.18% $26.83 V 99.78% 6
Sep 3, 2025 $46.00 +70.06% $26.83 X 28.55% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE